Keywords: king, pharma, profits, double, driven, altace, specialty
King Pharma profits more than double, driven by Altace
Article | 21 February 2001
US specialty drugmaker King Pharmaceuticals says that fourth-quarter2000 operating profits soared 114% to $54.9 million, excluding special charges, on the like, year-earlier ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US Supreme Court says patent settlement can "sometimes" be illegal
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
